305 related articles for article (PubMed ID: 10999817)
1. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.
Ibáñez L; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2000 Sep; 85(9):3251-5. PubMed ID: 10999817
[TBL] [Abstract][Full Text] [Related]
2. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
[TBL] [Abstract][Full Text] [Related]
4. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
[TBL] [Abstract][Full Text] [Related]
5. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
Ibáñez L; De Zegher F
J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
[TBL] [Abstract][Full Text] [Related]
6. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
Ibáñez L; López-Bermejo A; del Rio L; Enríquez G; Valls C; de Zegher F
J Clin Endocrinol Metab; 2007 May; 92(5):1710-4. PubMed ID: 17299064
[TBL] [Abstract][Full Text] [Related]
7. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
8. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.
Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1262-7. PubMed ID: 21632811
[TBL] [Abstract][Full Text] [Related]
9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
Ibáñez L; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726
[TBL] [Abstract][Full Text] [Related]
11. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
12. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
Diamanti-Kandarakis E; Mitrakou A; Raptis S; Tolis G; Duleba AJ
J Clin Endocrinol Metab; 1998 Aug; 83(8):2699-705. PubMed ID: 9709934
[TBL] [Abstract][Full Text] [Related]
13. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.
Paoletti AM; Cagnacci A; Orrù M; Ajossa S; Guerriero S; Melis GB
Fertil Steril; 1999 Sep; 72(3):448-53. PubMed ID: 10519615
[TBL] [Abstract][Full Text] [Related]
14. Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
Ibáñez L; Diaz M; Sebastiani G; Sánchez-Infantes D; Salvador C; Lopez-Bermejo A; de Zegher F
J Clin Endocrinol Metab; 2011 Nov; 96(11):3361-6. PubMed ID: 21865363
[TBL] [Abstract][Full Text] [Related]
15. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
Ibáñez L; de Zegher F
Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
[TBL] [Abstract][Full Text] [Related]
16. [Low-dose flutamide in the treatment of hyperandrogenism in adolescents].
Pizzo A; Borrielli I; Mastroeni MT; Fattori A; Dugo C; Dugo N; Dinatale A
Minerva Pediatr; 2008 Dec; 60(6):1357-66. PubMed ID: 18971896
[TBL] [Abstract][Full Text] [Related]
17. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
Moghetti P; Tosi F; Castello R; Magnani CM; Negri C; Brun E; Furlani L; Caputo M; Muggeo M
J Clin Endocrinol Metab; 1996 Mar; 81(3):952-60. PubMed ID: 8772557
[TBL] [Abstract][Full Text] [Related]
18. Very low dose of flutamide in the treatment of hyperandrogenism.
Fulghesu AM; Melis F; Murru G; Canu E; Melis GB
Gynecol Endocrinol; 2018 May; 34(5):394-398. PubMed ID: 29108453
[TBL] [Abstract][Full Text] [Related]
19. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.
Ibáñez L; Valls C; Ferrer A; Marcos MV; Rodriguez-Hierro F; de Zegher F
J Clin Endocrinol Metab; 2001 Aug; 86(8):3595-8. PubMed ID: 11502783
[TBL] [Abstract][Full Text] [Related]
20. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
Ibáñez L; de Zegher F
Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]